89BIO (ETNB) News Today $9.30 +0.20 (+2.14%) As of 03:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ETNB Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period University of Wisconsin Foundation Acquires 236,000 Shares of 89BIO $ETNBAugust 26 at 7:23 AM | marketbeat.com89bio price target lowered to $29 from $30 at BofAAugust 25 at 1:01 PM | msn.comCandriam S.C.A. Sells 223,838 Shares of 89BIO $ETNBAugust 24 at 6:18 AM | marketbeat.comErste Asset Management GmbH Has $6.50 Million Position in 89BIO $ETNBAugust 23 at 6:22 AM | marketbeat.comLord Abbett & CO. LLC Purchases New Shares in 89BIO (NASDAQ:ETNB)August 19, 2025 | marketbeat.com89BIO (NASDAQ:ETNB) Receives $26.29 Consensus PT from AnalystsAugust 19, 2025 | americanbankingnews.com89bio, Inc. (ETNB) Reports Second-Quarter Results; Leerink Partners and Citi Maintain ‘Buy’ RatingsAugust 19, 2025 | msn.com89BIO's (ETNB) "Sell (D-)" Rating Reiterated at Weiss RatingsAugust 16, 2025 | marketbeat.com89BIO (NASDAQ:ETNB) Given Consensus Recommendation of "Buy" by BrokeragesAugust 15, 2025 | marketbeat.comWeiss Ratings Reiterates "Sell (D-)" Rating for 89BIO (NASDAQ:ETNB)August 15, 2025 | americanbankingnews.com89BIO (NASDAQ:ETNB) Shares Down 5.2% After Analyst DowngradeAugust 12, 2025 | marketbeat.comFY2029 Earnings Estimate for 89BIO Issued By Leerink PartnrsAugust 12, 2025 | marketbeat.com89BIO (NASDAQ:ETNB) Releases Earnings Results, Misses Estimates By $0.22 EPSAugust 11, 2025 | marketbeat.com89bio: Promising As Pegozafermin Nears Phase 3 ReadoutAugust 11, 2025 | seekingalpha.com89BIO (NASDAQ:ETNB) Price Target Cut to $11.00 by Analysts at Royal Bank Of CanadaAugust 9, 2025 | marketbeat.com376,804 Shares in 89BIO (NASDAQ:ETNB) Bought by Vivo Capital LLCAugust 9, 2025 | marketbeat.com89bio (ETNB) Q2 R&D Jumps 131%August 7, 2025 | fool.com89bio Reports Second Quarter 2025 Financial Results and Corporate UpdatesAugust 7, 2025 | globenewswire.com89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 4, 2025 | globenewswire.com89BIO's (ETNB) "Sell (D-)" Rating Reaffirmed at Weiss RatingsJuly 30, 2025 | marketbeat.com226,050 Shares in 89BIO (NASDAQ:ETNB) Purchased by Royce & Associates LPJuly 29, 2025 | marketbeat.comBank of New York Mellon Corp Acquires 61,760 Shares of 89BIO (NASDAQ:ETNB)July 29, 2025 | marketbeat.com89BIO (ETNB) to Release Earnings on MondayJuly 28, 2025 | marketbeat.comReadystate Asset Management LP Buys New Shares in 89BIO (NASDAQ:ETNB)July 23, 2025 | marketbeat.com89BIO (NASDAQ:ETNB) Receives Consensus Rating of "Buy" from AnalystsJuly 20, 2025 | marketbeat.comInsider Selling: 89BIO (NASDAQ:ETNB) Insider Sells 10,461 Shares of StockJuly 18, 2025 | marketbeat.com89BIO (NASDAQ:ETNB) Insider Sells $115,280.22 in StockJuly 18, 2025 | insidertrades.com89BIO (NASDAQ:ETNB) Receives Sell (D-) Rating from Weiss RatingsJuly 14, 2025 | marketbeat.comEmerald Advisers LLC Invests $11.27 Million in 89BIO (NASDAQ:ETNB)July 13, 2025 | marketbeat.comEmerald Mutual Fund Advisers Trust Buys Shares of 1,082,973 89BIO (NASDAQ:ETNB)July 12, 2025 | marketbeat.com89bio, Inc. (ETNB) - Yahoo FinanceJuly 10, 2025 | finance.yahoo.com89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 9, 2025 | globenewswire.com89BIO (NASDAQ:ETNB) Stock Price Up 5% - Time to Buy?July 9, 2025 | marketbeat.com89BIO (NASDAQ:ETNB) Given Average Recommendation of "Buy" by AnalystsJune 25, 2025 | marketbeat.comAssenagon Asset Management S.A. Increases Holdings in 89bio, Inc. (NASDAQ:ETNB)June 16, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Trading Up 4.9% - What's Next?June 13, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Shares Down 4.8% - Here's What HappenedJune 12, 2025 | marketbeat.comHarbor Capital Advisors Inc. Buys 62,874 Shares of 89bio, Inc. (NASDAQ:ETNB)June 12, 2025 | marketbeat.comBrokers Offer Predictions for 89bio FY2026 EarningsJune 11, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCJune 9, 2025 | marketbeat.comHennion & Walsh Asset Management Inc. Raises Position in 89bio, Inc. (NASDAQ:ETNB)June 7, 2025 | marketbeat.com89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 6, 2025 | globenewswire.com89bio to Participate in Goldman Sachs 46th Annual Global Healthcare ConferenceJune 4, 2025 | globenewswire.comTwo Sigma Investments LP Sells 131,167 Shares of 89bio, Inc. (NASDAQ:ETNB)June 3, 2025 | marketbeat.comTwo Sigma Advisers LP Reduces Holdings in 89bio, Inc. (NASDAQ:ETNB)June 2, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Shares Bought by Bank of America Corp DEJune 2, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Given Consensus Recommendation of "Buy" by BrokeragesJune 1, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Shares Up 6.4% - Still a Buy?May 30, 2025 | marketbeat.com89bio (ETNB) Receives a Buy from Bank of America SecuritiesMay 29, 2025 | theglobeandmail.com89bio (NASDAQ:ETNB) Shares Gap Up - Here's What HappenedMay 29, 2025 | marketbeat.com Get 89BIO News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address ETNB Media Mentions By Week ETNB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETNB News Sentiment▼0.890.70▲Average Medical News Sentiment ETNB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETNB Articles This Week▼55▲ETNB Articles Average Week Get 89BIO News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Axsome Therapeutics News CRISPR Therapeutics News Abivax News Merus News Cytokinetics News Viking Therapeutics News TG Therapeutics News Krystal Biotech News ACADIA Pharmaceuticals News Vaxcyte News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ETNB) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 89BIO Please log in to your account or sign up in order to add this asset to your watchlist. Share 89BIO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access